申请人:GLOBAL BLOOD THERAPEUTICS, INC.
公开号:US20160024127A1
公开(公告)日:2016-01-28
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.